Table 4

Significant results of general linear model repeated measures analysis of variance test determining the effects of treatment and other independent variables on 1-year changes in positron emission tomography/CT parameters as dependent variables

Dependent variableEffectFP valuePartial η2
SUV-SYNmean 0–12Treatment * RANKL-04.6190.0460.214
TBR-SYNmean 0–12Treatment * RANKL-011.7770.0020.409
TBR-VASCmean 0–12Treatment * ESR-09.8990.0060.368
Treatment * DXAL24BMD-0 (inv)5.4850.0320.244
TBR-VASCmax 0–12Treatment * ESR-07.5350.0140.307
Tretament * DXAL24BMD-0 (inv)4.8260.0420.221
  • The numbers -0 and -12 indicate values at baseline and after 12 months of treatment.

  • BMD, bone mineral density; DXA, dual-energy X-ray absorptiometry; ESR, erythrocyte sedimentation rate; GLM, general linear model; L24, lumbar 2–4 vertebrae; max, maximum; RANKL, receptor activator nuclear factor κB ligand; SUV, standardised uptake value; TBR, target-to-background ratio; VASC, vascular.